The landscape of dementia analysis has developed radically with the advent of innovative biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based exams which will detect Alzheimer's pathology decades prior to signs arise. Though these technological advances signify impressive development in being familiar with neurodegene